| Primary |
| Breast Cancer |
57.4% |
| Diffuse Large B-cell Lymphoma |
14.5% |
| Product Used For Unknown Indication |
9.5% |
| Non-hodgkin's Lymphoma |
2.7% |
| B-cell Lymphoma |
2.5% |
| Burkitt's Lymphoma |
2.2% |
| Malignant Lymphoid Neoplasm |
1.9% |
| Malignant Breast Neoplasm |
1.4% |
| Drug Use For Unknown Indication |
1.2% |
| Disease Progression |
1.1% |
| Granulomatosis With Polyangiitis |
1.1% |
| Chronic Lymphocytic Leukaemia |
0.6% |
| Prophylaxis |
0.6% |
| Breast Ductal Carcinoma |
0.5% |
| Chemotherapy |
0.5% |
| Chronic Lymphocytic Leukemia |
0.5% |
| Dyspepsia |
0.5% |
| Hypertension |
0.5% |
| Juvenile Idiopathic Arthritis |
0.5% |
| Plasma Cell Myeloma |
0.5% |
|
| Metastasis |
41.9% |
| Malignant Respiratory Tract Neoplasm |
10.5% |
| Oesophageal Carcinoma |
7.6% |
| Endometrial Cancer |
5.7% |
| Metastases To Reproductive Organ |
5.7% |
| Pyrexia |
3.8% |
| Infection |
2.9% |
| Progressive Multifocal Leukoencephalopathy |
2.9% |
| Sepsis |
2.9% |
| Skin Infection |
2.9% |
| Disease Progression |
1.9% |
| Myocardial Ischaemia |
1.9% |
| Pulmonary Embolism |
1.9% |
| Weight Decreased |
1.9% |
| Cerebral Haemorrhage |
1.0% |
| Diarrhoea |
1.0% |
| Diverticulitis |
1.0% |
| Encephalitis |
1.0% |
| Haematological Malignancy |
1.0% |
| Histiocytosis Haematophagic |
1.0% |
|
| Secondary |
| Product Used For Unknown Indication |
17.2% |
| Hodgkin's Disease |
16.9% |
| Breast Cancer |
16.0% |
| Diffuse Large B-cell Lymphoma |
15.9% |
| Drug Use For Unknown Indication |
5.0% |
| Breast Cancer Metastatic |
4.1% |
| B-cell Lymphoma |
3.6% |
| Chronic Lymphocytic Leukaemia |
3.5% |
| Malignant Breast Neoplasm |
2.3% |
| Prostate Cancer |
2.1% |
| Hypertension |
1.8% |
| Non-hodgkin's Lymphoma |
1.8% |
| Depression |
1.5% |
| Prophylaxis |
1.5% |
| Anticoagulant Therapy |
1.2% |
| Lymphoma |
1.2% |
| Chemotherapy |
1.1% |
| Colony Stimulating Factor Therapy |
1.1% |
| Dyspepsia |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
|
| Peripheral Sensory Neuropathy |
13.8% |
| Pyrexia |
7.7% |
| Skin Infection |
7.7% |
| Weight Decreased |
7.7% |
| Pulmonary Embolism |
6.2% |
| Pulmonary Fibrosis |
6.2% |
| Thrombocytopenia |
6.2% |
| Disease Progression |
4.6% |
| Nausea |
4.6% |
| Rash |
4.6% |
| Diarrhoea |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Myelodysplastic Syndrome |
3.1% |
| Oedema Peripheral |
3.1% |
| Pain In Extremity |
3.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.1% |
| Peroneal Nerve Palsy |
3.1% |
| Pneumonia |
3.1% |
| Pneumonitis |
3.1% |
| Progressive Multifocal Leukoencephalopathy |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
40.6% |
| Diffuse Large B-cell Lymphoma |
13.7% |
| Breast Cancer |
6.1% |
| Chronic Lymphocytic Leukaemia |
4.2% |
| Pneumonia |
3.8% |
| B-cell Lymphoma |
3.3% |
| Diabetes Mellitus |
2.8% |
| Hypercholesterolaemia |
2.8% |
| Hypertension |
2.8% |
| Scleroderma |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Product Used For Unknown Indication |
2.4% |
| Multiple Myeloma |
1.9% |
| Atrial Fibrillation |
1.4% |
| Bronchospasm |
1.4% |
| Burkitt's Lymphoma |
1.4% |
| Chemotherapy |
1.4% |
| Diuretic Therapy |
1.4% |
| Electrolyte Substitution Therapy |
1.4% |
| Lymphatic Disorder |
1.4% |
|
| Osteonecrosis |
17.1% |
| Pneumonitis |
12.2% |
| Cardiac Arrest |
7.3% |
| Oedema |
7.3% |
| Progressive Multifocal Leukoencephalopathy |
7.3% |
| Vith Nerve Paralysis |
7.3% |
| Pleural Effusion |
4.9% |
| Tooth Extraction |
4.9% |
| White Blood Cell Disorder |
4.9% |
| Deafness Bilateral |
2.4% |
| Death |
2.4% |
| Dyspnoea |
2.4% |
| Encephalopathy |
2.4% |
| Febrile Neutropenia |
2.4% |
| Hepatitis |
2.4% |
| Ischaemic Stroke |
2.4% |
| Neuropathy Peripheral |
2.4% |
| Osteonecrosis Of Jaw |
2.4% |
| Pain |
2.4% |
| Pulmonary Fibrosis |
2.4% |
|
